Kyntra Bio, Inc. (KYNB)
3.73
+0.07
(+1.91%)
USD |
NASDAQ |
Nov 06, 16:00
3.79
+0.06
(+1.61%)
After-Hours: 20:00
Kyntra Bio Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 19.25M |
| December 31, 2025 | 19.56M |
| September 30, 2025 | 21.04M |
| June 30, 2025 | 93.13M |
| March 31, 2025 | 91.22M |
| December 31, 2024 | 90.21M |
| September 30, 2024 | 91.68M |
| June 30, 2024 | 148.25M |
| March 31, 2024 | 153.38M |
| December 31, 2023 | 154.86M |
| September 30, 2023 | 158.64M |
| June 30, 2023 | 162.59M |
| March 31, 2023 | 94.16M |
| December 31, 2022 | 96.68M |
| September 30, 2022 | 96.51M |
| June 30, 2022 | 99.52M |
| March 31, 2022 | 103.32M |
| December 31, 2021 | 106.40M |
| September 30, 2021 | 109.41M |
| June 30, 2021 | 112.50M |
| March 31, 2021 | 55.99M |
| December 31, 2020 | 57.27M |
| September 30, 2020 | 59.93M |
| June 30, 2020 | 62.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 65.20M |
| December 31, 2019 | 62.62M |
| September 30, 2019 | 71.49M |
| June 30, 2019 | 74.38M |
| March 31, 2019 | 76.70M |
| December 31, 2018 | 107.96M |
| September 30, 2018 | 114.27M |
| June 30, 2018 | 114.45M |
| March 31, 2018 | 115.44M |
| December 31, 2017 | 109.11M |
| September 30, 2017 | 114.29M |
| June 30, 2017 | 113.74M |
| March 31, 2017 | 112.69M |
| December 31, 2016 | 107.31M |
| September 30, 2016 | 113.12M |
| June 30, 2016 | 112.91M |
| March 31, 2016 | 112.86M |
| December 31, 2015 | 107.33M |
| September 30, 2015 | 112.42M |
| June 30, 2015 | 112.12M |
| March 31, 2015 | 111.65M |
| December 31, 2014 | 108.69M |
| September 30, 2014 | 114.07M |
| June 30, 2014 | 96.91M |
| March 31, 2014 | 96.86M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Nektar Therapeutics | 113.23M |
| Capricor Therapeutics, Inc. | 89.56M |
| ARS Pharmaceuticals, Inc. | 121.81M |
| ACADIA Pharmaceuticals, Inc. | 57.32M |
| Alnylam Pharmaceuticals, Inc. | 2.951B |